This Week in Science

A team of Harvard University researchers reports in Science on its examination of insertion mutations into the EGFR exon 20 in non–small cell lung cancer. These mutations, the team notes, are associated with reduced sensitivity to tyrosine kinase inhibitors like gefitinib, erlotinib, and afatinib, which they confirmed in an in vitro study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.